Four teams of our expert “Lizards” took 24 hours to develop applications that used the power of chatbots based on large language models (LLMs) to tackle challenges commonly encountered in biotech.

We’re proud to be part of the flourishing healthtech cluster in Ghent.

 Our partnership with the Pistoia Alliance is a perfect fit with our ongoing commitment to our core values of being one step ahead, acting in good conscience, collaborating radically, and being driven by excellence.

On June 23rd 2023, BioLizard hosted a Bits in Bio Belgium meeting, which drew over fifty attendees to listen in to a series of three talks – with a healthy dose of networking and pizza on the side.

Volodimir Olexiouk, our Director of Scientific Engagement and AI & Analytics Team Lead, was a panelist in the discussion, ‘AI on the verge of breakthrough in healthcare: How to monetise while creating patient impact’.

This collaboration marks a significant milestone for BioLizard as it sets its sights on expanding its reach and exploring new international markets.

The new board will focus on investments in innovation and a sustainable growth in Europe and the US.

Tercen and BioLizard today announced their partnership.

We are incredibly proud to announce that Liesbeth Ceelen, CEO of BioLizard, was awarded the honour of being named one of the leading women in Belgian tech for 2022.  

BioLizard is proud to join the REPO4EU consortium.